30
Participants
Start Date
April 11, 2008
Primary Completion Date
June 7, 2008
Study Completion Date
June 7, 2008
CAT-354 150 mg (intravenous)
A single dose of CAT-354 150 milligram (mg) intravenous infusion over 30 minutes on Day 0.
CAT-354 150 mg (subcutaneous)
A single dose of CAT-354 150 mg injection subcutaneously on Day 0.
CAT-354 300 mg (subcutaneous)
A single dose of CAT-354 300 mg injection subcutaneously on Day 0.
MDS Pharma Services (US) Inc., Lincoln
Lead Sponsor
MedImmune LLC
INDUSTRY